Meeting
2019 Gastrointestinal Cancers Symposium
The efficacy of neoadjuvant treatment in locally advanced rectal cancer with dMMR.
Authors
Yanhong Deng
Sun Yat-sen University, Guangzhou, China
Yanhong Deng , Jianwei Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 615)
DOI
10.1200/JCO.2019.37.4_suppl.615
Abstract #
615
Poster Bd #
J18
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Neoadjuvant chemotherapy with mFOLFOXIRI alone for cT4 and fixed cT3 rectal cancer: Results from a single arm phase II study (FORTUNE).
First Author: Jianwei Zhang
Poster
2019 ASCO Annual Meeting
Effect of neoadjuvant treatment on locally advanced rectal mucinous adenocarcinoma or signet-ring cell carcinoma: A post-hoc analysis from 3 prospective studies.
First Author: Jianwei Zhang
Poster
2016 Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy alone with mFOLFOXIRI in locally advanced rectal cancer: A single-arm phase II study.
First Author: Yanhong Deng
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Efficacy and safety of neoadjuvant preoperative short-course radiation followed by envafolimab plus CAPEOX in microsatellite stable (MSS)/mismatch repair proficient (pMMR) locally advanced rectal cancer.
First Author: Sheng Dai